1. Home
  2. LTRN vs NTWK Comparison

LTRN vs NTWK Comparison

Compare LTRN & NTWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • NTWK
  • Stock Information
  • Founded
  • LTRN 2013
  • NTWK 1997
  • Country
  • LTRN United States
  • NTWK United States
  • Employees
  • LTRN N/A
  • NTWK N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • NTWK Computer Software: Prepackaged Software
  • Sector
  • LTRN Health Care
  • NTWK Technology
  • Exchange
  • LTRN Nasdaq
  • NTWK Nasdaq
  • Market Cap
  • LTRN 49.9M
  • NTWK 56.1M
  • IPO Year
  • LTRN 2020
  • NTWK 1998
  • Fundamental
  • Price
  • LTRN $3.90
  • NTWK $4.40
  • Analyst Decision
  • LTRN Strong Buy
  • NTWK
  • Analyst Count
  • LTRN 1
  • NTWK 0
  • Target Price
  • LTRN $25.00
  • NTWK N/A
  • AVG Volume (30 Days)
  • LTRN 164.4K
  • NTWK 93.1K
  • Earning Date
  • LTRN 11-14-2025
  • NTWK 11-12-2025
  • Dividend Yield
  • LTRN N/A
  • NTWK N/A
  • EPS Growth
  • LTRN N/A
  • NTWK 316.67
  • EPS
  • LTRN N/A
  • NTWK 0.25
  • Revenue
  • LTRN N/A
  • NTWK $66,088,229.00
  • Revenue This Year
  • LTRN N/A
  • NTWK N/A
  • Revenue Next Year
  • LTRN N/A
  • NTWK N/A
  • P/E Ratio
  • LTRN N/A
  • NTWK $17.64
  • Revenue Growth
  • LTRN N/A
  • NTWK 7.65
  • 52 Week Low
  • LTRN $2.55
  • NTWK $2.14
  • 52 Week High
  • LTRN $6.12
  • NTWK $5.75
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 42.88
  • NTWK 46.50
  • Support Level
  • LTRN $3.80
  • NTWK $4.30
  • Resistance Level
  • LTRN $4.28
  • NTWK $4.69
  • Average True Range (ATR)
  • LTRN 0.30
  • NTWK 0.18
  • MACD
  • LTRN -0.04
  • NTWK -0.03
  • Stochastic Oscillator
  • LTRN 14.29
  • NTWK 17.33

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About NTWK NetSol Technologies Inc. Common Stock

NETSOL Technologies Inc is an information technology and enterprise software solutions provider to original equipment manufacturers (OEMs), dealerships, and financial institutions to sell, finance, and lease assets. The firm's products include Transcend Retail, Transcend Finance, Transcend Marketplace, Transcend Consultancy, and Transcend AI Labs, catering to its customers in the different stages of how assets are sold, financed, and leased. Its primary sources of revenue are licensing, subscriptions, modification, enhancement, and support of its suite of financial applications offered to businesses in the finance and leasing space, as well as automotive digital retail. The company has three reportable segments: Asia-Pacific, its key revenue-generating market, North America, and Europe.

Share on Social Networks: